Diaceutics PLC (LON:DXRX – Get Free Report)’s share price fell 2.5% during mid-day trading on Monday . The company traded as low as GBX 126 and last traded at GBX 126.61. 25,462 shares were traded during trading, a decline of 81% from the average session volume of 136,461 shares. The stock had previously closed at GBX 129.80.
Diaceutics Stock Down 2.5%
The firm has a market capitalization of £107.14 million, a PE ratio of -70.34 and a beta of 0.58. The business’s 50 day simple moving average is GBX 153.61 and its 200 day simple moving average is GBX 142.38. The company has a current ratio of 4.85, a quick ratio of 9.92 and a debt-to-equity ratio of 0.39.
Diaceutics (LON:DXRX – Get Free Report) last announced its earnings results on Tuesday, September 23rd. The company reported GBX (2.84) earnings per share (EPS) for the quarter. Diaceutics had a negative net margin of 10.90% and a negative return on equity of 7.15%. On average, equities research analysts forecast that Diaceutics PLC will post 1.0107919 earnings per share for the current year.
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.
Featured Stories
- Five stocks we like better than Diaceutics
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Can Any Expenses Be Deducted From Capital Gains Tax?
- The Last Gold Bull Market
Receive News & Ratings for Diaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diaceutics and related companies with MarketBeat.com's FREE daily email newsletter.
